Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0128 USD | -19,25% | -5,88% | -80,00% |
Omzet 2022 | 16,84 15,72 | Omzet 2023 | 18,22 17,01 | Marktkapitalisatie | 1,28 mln. 1,2 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -76 mln. -70,97 mln. | Nettowinst (verlies) 2023 | 53 mln. 49,49 mln. | EV/omzet 2022 | 4.528.434 x |
Nettoschuld 2022 | 68,36 mln. 63,83 mln. | Nettoschuld 2023 | 43,37 mln. 40,5 mln. | EV/omzet 2023 | 2.451.077 x |
K/w-verhouding 2022 |
-0,05
x | K/w-verhouding 2023 |
1,2
x | Werknemers | 38 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 100% |
Recentste transcriptie over Evofem Biosciences, Inc.
1 dag | -19,25% | ||
1 week | -5,88% | ||
Lopende maand | -46,89% | ||
1 maand | -33,33% | ||
3 maanden | -57,05% | ||
6 maanden | -84,94% | ||
Lopend jaar | -80,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-01-13 | |
Ivy Zhang
DFI | Director of Finance/CFO | 46 | 01-03-18 |
Amy Raskopf
IRC | Investor Relations Contact | - | 01-02-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-01-13 | |
Kim Kamdar
BRD | Director/Board Member | 56 | 01-01-18 |
Colin Rutherford
BRD | Director/Board Member | 65 | 01-01-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 0,0159 | +3,25% | 157 974 |
19-04-24 | 0,0154 | +9,22% | 369 086 |
18-04-24 | 0,0141 | +3,68% | 182 360 |
17-04-24 | 0,0136 | -11,11% | 603 016 |
16-04-24 | 0,0153 | +2,00% | 560 939 |
uitgestelde koers OTC Markets, 23 april 2024 om 21:58 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-80,00% | 858K | |
+27,92% | 659 mld. | |
+27,68% | 557 mld. | |
-4,59% | 359 mld. | |
+16,38% | 322 mld. | |
+9,39% | 297 mld. | |
+6,30% | 215 mld. | |
+4,80% | 210 mld. | |
-6,05% | 200 mld. | |
-8,58% | 149 mld. |